This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Gotoh, N. Articles by Shibuya, M. Search for Related Content PubMed PubMed Citation Articles by Gotoh, N. Articles by Shibuya, M.

 Previous Article  |  Next Article 

Mol. Cell. Biol., 04 1997, 1824-1831, Vol 17, No. 4
Copyright © 1997, American Society for Microbiology

Tyrosine phosphorylation sites at amino acids 239 and 240 of Shc are involved in epidermal growth factor-induced mitogenic signaling that is distinct from Ras/mitogen-activated protein kinase activation

N Gotoh, M Toyoda and M Shibuya
Department of Genetics, Institute of Medical Science, University of Tokyo, Japan.

Epidermal growth factor (EGF) induces tyrosine phosphorylation of the Shc adapter protein, which plays an important role in EGF-stimulated mitogenesis. Shc stimulates Ras/mitogen-activated protein kinase (MAPK) through forming a complex with Grb2 at the phosphorylated tyrosine (Y) residue 317. In this study, we identified novel phosphorylation sites of Shc, at Y239 and Y240. To define the Shc pathway further, we used NIH 3T3 cells expressing the previously characterized mutant EGF receptor (EGF-R) which lacks all known autophosphorylation sites but retains EGF-stimulated mitogenesis with selective phosphorylation of Shc. We constructed wild-type (WT) or mutant Shc cDNAs in which Y317 or/and Y239 and Y240 are replaced with phenylalanine (F) and introduced them into NIH 3T3 cells expressing WT or mutant EGF-R. In the WT EGF-R- expressing cells, the Y239/240/317F Shc, but not Y317F or Y239/240F Shc, decreased EGF-stimulated cell growth. In the mutant EGF-R- expressing cells, Y317F Shc or Y239/240F Shc decreased EGF-stimulated cell growth significantly, though Y317F was a little more potent than Y239/240F. Although cells expressing the Y317F Shc hardly activated MAPK in response to EGF, cells expressing the Y239/240F Shc fully activated MAPK. In contrast, Y239/240F Shc, but not Y317F Shc, reduced the EGF-induced c-myc message. These results suggest that Shc activates two distinct signaling pathways, Y317 to Ras/MAPK and Y239 and Y240 to another pathway including Myc, and that both are involved in EGF- induced mitogenic signaling.

This article has been cited by other articles:

• Xi, G., Shen, X., Clemmons, D. R. (2008). p66shc Negatively Regulates Insulin-Like Growth Factor I Signal Transduction via Inhibition of p52shc Binding to Src Homology 2 Domain-Containing Protein Tyrosine Phosphatase Substrate-1 Leading to Impaired Growth Factor Receptor-Bound Protein-2 Membrane Recruitment. Mol. Endocrinol. 22: 2162-2175 [Abstract] [Full Text]  
• Northey, J. J., Chmielecki, J., Ngan, E., Russo, C., Annis, M. G., Muller, W. J., Siegel, P. M. (2008). Signaling through ShcA Is Required for Transforming Growth Factor {beta}- and Neu/ErbB-2-Induced Breast Cancer Cell Motility and Invasion. Mol. Cell. Biol. 28: 3162-3176 [Abstract] [Full Text]  
• Kraut-Cohen, J., Muller, W. J., Elson, A. (2008). Protein-tyrosine Phosphatase {epsilon} Regulates Shc Signaling in a Kinase-specific Manner: INCREASING COHERENCE IN TYROSINE PHOSPHATASE SIGNALING. J. Biol. Chem. 283: 4612-4621 [Abstract] [Full Text]  
• Jones, N., Hardy, W. R., Friese, M. B., Jorgensen, C., Smith, M. J., Woody, N. M., Burden, S. J., Pawson, T. (2007). Analysis of a Shc Family Adaptor Protein, ShcD/Shc4, That Associates with Muscle-Specific Kinase. Mol. Cell. Biol. 27: 4759-4773 [Abstract] [Full Text]  
• Chintapalli, J., Yang, S., Opawumi, D., Goyal, S. R., Shamsuddin, N., Malhotra, A., Reiss, K., Meggs, L. G. (2007). Inhibition of wild-type p66ShcA in mesangial cells prevents glycooxidant-dependent FOXO3a regulation and promotes the survival phenotype. Am. J. Physiol. Renal Physiol. 292: F523-F530 [Abstract] [Full Text]  
• Obreztchikova, M., Elouardighi, H., Ho, M., Wilson, B. A., Gertsberg, Z., Steinberg, S. F. (2006). Distinct Signaling Functions for Shc Isoforms in the Heart. J. Biol. Chem. 281: 20197-20204 [Abstract] [Full Text]  
• Veracini, L., Franco, M., Boureux, A., Simon, V., Roche, S., Benistant, C. (2006). Two distinct pools of Src family tyrosine kinases regulate PDGF-induced DNA synthesis and actin dorsal ruffles. J. Cell Sci. 119: 2921-2934 [Abstract] [Full Text]  
• Franco, M., Furstoss, O., Simon, V., Benistant, C., Hong, W. J., Roche, S. (2006). The Adaptor Protein Tom1L1 Is a Negative Regulator of Src Mitogenic Signaling Induced by Growth Factors.. Mol. Cell. Biol. 26: 1932-1947 [Abstract] [Full Text]  
• Zhang, Y., Wolf-Yadlin, A., Ross, P. L., Pappin, D. J., Rush, J., Lauffenburger, D. A., White, F. M. (2005). Time-resolved Mass Spectrometry of Tyrosine Phosphorylation Sites in the Epidermal Growth Factor Receptor Signaling Network Reveals Dynamic Modules. Mol. Cell. Proteomics 4: 1240-1250 [Abstract] [Full Text]  
• Boureux, A., Furstoss, O., Simon, V., Roche, S. (2005). Abl tyrosine kinase regulates a Rac/JNK and a Rac/Nox pathway for DNA synthesis and Myc expression induced by growth factors. J. Cell Sci. 118: 3717-3726 [Abstract] [Full Text]  
• Graiani, G., Lagrasta, C., Migliaccio, E., Spillmann, F., Meloni, M., Madeddu, P., Quaini, F., Padura, I. M., Lanfrancone, L., Pelicci, P., Emanueli, C. (2005). Genetic Deletion of the p66Shc Adaptor Protein Protects From Angiotensin II-Induced Myocardial Damage. Hypertension 46: 433-440 [Abstract] [Full Text]  
• Newton, C. S., Loukinova, E., Mikhailenko, I., Ranganathan, S., Gao, Y., Haudenschild, C., Strickland, D. K. (2005). Platelet-derived Growth Factor Receptor-{beta} (PDGFR-{beta}) Activation Promotes Its Association with the Low Density Lipoprotein Receptor-related Protein (LRP): EVIDENCE FOR CO-RECEPTOR FUNCTION. J. Biol. Chem. 280: 27872-27878 [Abstract] [Full Text]  
• Lee, M. K., Pryhuber, G. S., Schwarz, M. A., Smith, S. M., Pavlova, Z., Sunday, M. E. (2005). Developmental Regulation of p66Shc Is Altered by Bronchopulmonary Dysplasia in Baboons and Humans. Am. J. Respir. Crit. Care Med. 171: 1384-1394 [Abstract] [Full Text]  
• Ranganathan, S., Liu, C.-X., Migliorini, M. M., von Arnim, C. A. F., Peltan, I. D., Mikhailenko, I., Hyman, B. T., Strickland, D. K. (2004). Serine and Threonine Phosphorylation of the Low Density Lipoprotein Receptor-related Protein by Protein Kinase C{alpha} Regulates Endocytosis and Association with Adaptor Molecules. J. Biol. Chem. 279: 40536-40544 [Abstract] [Full Text]  
• Fan, Y.-X., Wong, L., Deb, T. B., Johnson, G. R. (2004). Ligand Regulates Epidermal Growth Factor Receptor Kinase Specificity: ACTIVATION INCREASES PREFERENCE FOR GAB1 AND SHC VERSUS AUTOPHOSPHORYLATION SITES. J. Biol. Chem. 279: 38143-38150 [Abstract] [Full Text]  
• Murayama, Y., Miyagawa, J.-i., Oritani, K., Yoshida, H., Yamamoto, K., Kishida, O., Miyazaki, T., Tsutsui, S., Kiyohara, T., Miyazaki, Y., Higashiyama, S., Matsuzawa, Y., Shinomura, Y. (2004). CD9-mediated activation of the p46 Shc isoform leads to apoptosis in cancer cells. J. Cell Sci. 117: 3379-3388 [Abstract] [Full Text]  
• Leahy, M., Lyons, A., Krause, D., O'Connor, R. (2004). Impaired Shc, Ras, and MAPK Activation but Normal Akt Activation in FL5.12 Cells Expressing an Insulin-like Growth Factor I Receptor Mutated at Tyrosines 1250 and 1251. J. Biol. Chem. 279: 18306-18313 [Abstract] [Full Text]  
• Saucier, C., Khoury, H., Lai, K.-M. V., Peschard, P., Dankort, D., Naujokas, M. A., Holash, J., Yancopoulos, G. D., Muller, W. J., Pawson, T., Park, M. (2004). The Shc adaptor protein is critical for VEGF induction by Met/HGF and ErbB2 receptors and for early onset of tumor angiogenesis. Proc. Natl. Acad. Sci. USA 101: 2345-2350 [Abstract] [Full Text]  
• Davol, P. A., Bagdasaryan, R., Elfenbein, G. J., Maizel, A. L., Frackelton, A. R. Jr. (2003). Shc Proteins Are Strong, Independent Prognostic Markers for Both Node-Negative and Node-Positive Primary Breast Cancer. Cancer Res. 63: 6772-6783 [Abstract] [Full Text]  
• Beebe, J. A., Wiepz, G. J., Guadarrama, A. G., Bertics, P. J., Burke, T. J. (2003). A Carboxyl-terminal Mutation of the Epidermal Growth Factor Receptor Alters Tyrosine Kinase Activity and Substrate Specificity as Measured by a Fluorescence Polarization Assay. J. Biol. Chem. 278: 26810-26816 [Abstract] [Full Text]  
• Abe, J.-i., Berk, B. C. (2002). Hypoxia and HIF-1{alpha} Stability: Another Stress-Sensing Mechanism for Shc. Circ. Res. 91: 4-6 [Full Text]  
• Loukinova, E., Ranganathan, S., Kuznetsov, S., Gorlatova, N., Migliorini, M. M., Loukinov, D., Ulery, P. G., Mikhailenko, I., Lawrence, D. A., Strickland, D. K. (2002). Platelet-derived Growth Factor (PDGF)-induced Tyrosine Phosphorylation of the Low Density Lipoprotein Receptor-related Protein (LRP). EVIDENCE FOR INTEGRATED CO-RECEPTOR FUNCTION BETWEEN LRP AND THE PDGF. J. Biol. Chem. 277: 15499-15506 [Abstract] [Full Text]  
• Iwashima, M., Takamatsu, M., Yamagishi, H., Hatanaka, Y., Huang, Y.-Y., McGinty, C., Yamasaki, S., Koike, T. (2002). Genetic evidence for Shc requirement in TCR-induced c-Rel nuclear translocation and IL-2 expression. Proc. Natl. Acad. Sci. USA 99: 4544-4549 [Abstract] [Full Text]  
• Sasaoka, T., Ishiki, M., Wada, T., Hori, H., Hirai, H., Haruta, T., Ishihara, H., Kobayashi, M. (2001). Tyrosine Phosphorylation-Dependent and -Independent Role of Shc in the Regulation of IGF-1-Induced Mitogenesis and Glycogen Synthesis. Endocrinology 142: 5226-5235 [Abstract] [Full Text]  
• Dankort, D., Jeyabalan, N., Jones, N., Dumont, D. J., Muller, W. J. (2001). Multiple ErbB-2/Neu Phosphorylation Sites Mediate Transformation through Distinct Effector Proteins. J. Biol. Chem. 276: 38921-38928 [Abstract] [Full Text]  
• Dunican, D. J., Williams, E. J., Howell, F. V., Doherty, P. (2001). Selective Inhibition of Fibroblast Growth Factor (FGF)-stimulated Mitogenesis by a FGF Receptor-1-derived Phosphopeptide. Cell Growth Differ. 12: 255-264 [Abstract] [Full Text]  
• Dankort, D., Maslikowski, B., Warner, N., Kanno, N., Kim, H., Wang, Z., Moran, M. F., Oshima, R. G., Cardiff, R. D., Muller, W. J. (2001). Grb2 and Shc Adapter Proteins Play Distinct Roles in Neu (ErbB-2)-Induced Mammary Tumorigenesis: Implications for Human Breast Cancer. Mol. Cell. Biol. 21: 1540-1551 [Abstract] [Full Text]  
• Brock, R., Jovin, T. M. (2001). Heterogeneity of signal transduction at the subcellular level: microsphere-based focal EGF receptor activation and stimulation of Shc translocation. J. Cell Sci. 114: 2437-2447 [Abstract] [Full Text]  
• Blake, R. A., Broome, M. A., Liu, X., Wu, J., Gishizky, M., Sun, L., Courtneidge, S. A. (2000). SU6656, a Selective Src Family Kinase Inhibitor, Used To Probe Growth Factor Signaling. Mol. Cell. Biol. 20: 9018-9027 [Abstract] [Full Text]  
• Velazquez, L., Gish, G. D., van der Geer, P., Taylor, L., Shulman, J., Pawson, T. (2000). The Shc adaptor protein forms interdependent phosphotyrosine-mediated protein complexes in mast cells stimulated with interleukin 3. Blood 96: 132-138 [Abstract] [Full Text]  
• Jackson, J. G., Yoneda, T., Clark, G. M., Yee, D. (2000). Elevated Levels of p66 Shc Are Found in Breast Cancer Cell Lines and Primary Tumors with High Metastatic Potential. Clin. Cancer Res. 6: 1135-1139 [Abstract] [Full Text]  
• Lord, J. D., McIntosh, B. C., Greenberg, P. D., Nelson, B. H. (2000). The IL-2 Receptor Promotes Lymphocyte Proliferation and Induction of the c-myc, bcl-2, and bcl-x Genes Through the trans-Activation Domain of Stat5. J. Immunol. 164: 2533-2541 [Abstract] [Full Text]  
• Collins, L. R., Ricketts, W. A., Yeh, L., Cheresh, D. (1999). Bifurcation of Cell Migratory and Proliferative Signaling by the Adaptor Protein Shc. J. Cell Biol. 147: 1561-1568 [Abstract] [Full Text]  
• Rauh, M. J., Blackmore, V., Andrechek, E. R., Tortorice, C. G., Daly, R., Lai, V. K.-M., Pawson, T., Cardiff, R. D., Siegel, P. M., Muller, W. J. (1999). Accelerated Mammary Tumor Development in Mutant Polyomavirus Middle T Transgenic Mice Expressing Elevated Levels of Either the Shc or Grb2 Adapter Protein. Mol. Cell. Biol. 19: 8169-8179 [Abstract] [Full Text]  
• Ricketts, W. A., Brown, J. H., Olefsky, J. M. (1999). Pertussis Toxin-Sensitive and -Insensitive Thrombin Stimulation of Shc Phosphorylation and Mitogenesis Are Mediated through Distinct Pathways. Mol. Endocrinol. 13: 1988-2001 [Abstract] [Full Text]  
• Band, C. J., Mounier, C., Posner, B. I. (1999). Epidermal Growth Factor and Insulin-Induced Deoxyribonucleic Acid Synthesis in Primary Rat Hepatocytes Is Phosphatidylinositol 3-Kinase Dependent and Dissociated from Protooncogene Induction. Endocrinology 140: 5626-5634 [Abstract] [Full Text]  
• Heldin, C.-H., Westermark, B. (1999). Mechanism of Action and In Vivo Role of Platelet-Derived Growth Factor. Physiol. Rev. 79: 1283-1316 [Abstract] [Full Text]  
• Pratt, J. C., van den Brink, M. R. M., Igras, V. E., Walk, S. F., Ravichandran, K. S., Burakoff, S. J. (1999). Requirement for Shc in TCR-Mediated Activation of a T Cell Hybridoma. J. Immunol. 163: 2586-2591 [Abstract] [Full Text]  
• Palmer, H. J., Tuzon, C. T., Paulson, K. E. (1999). Age-dependent Decline in Mitogenic Stimulation of Hepatocytes. REDUCED ASSOCIATION BETWEEN Shc AND THE EPIDERMAL GROWTH FACTOR RECEPTOR IS COUPLED TO DECREASED ACTIVATION OF Raf AND EXTRACELLULAR SIGNAL-REGULATED KINASES. J. Biol. Chem. 274: 11424-11430 [Abstract] [Full Text]  
• Hossain, M. Z., Jagdale, A. B., Ao, P., Kazlauskas, A., Boynton, A. L. (1999). Disruption of Gap Junctional Communication by the Platelet-derived Growth Factor Is Mediated via Multiple Signaling Pathways. J. Biol. Chem. 274: 10489-10496 [Abstract] [Full Text]  
• Stevenson, L. E., Ravichandran, K. S., Frackelton, A. R. Jr. (1999). Shc Dominant Negative Disrupts Cell Cycle Progression in Both G0-G1 and G2-M of ErbB2-positive Breast Cancer Cells. Cell Growth Differ. 10: 61-71 [Abstract] [Full Text]  
• Lord, J. D., McIntosh, B. C., Greenberg, P. D., Nelson, B. H. (1998). The IL-2 Receptor Promotes Proliferation, bcl-2 and bcl-x Induction, But Not Cell Viability Through the Adapter Molecule Shc. J. Immunol. 161: 4627-4633 [Abstract] [Full Text]  
• Okkenhaug, K., Rottapel, R. (1998). Grb2 Forms an Inducible Protein Complex with CD28 through a Src Homology 3 Domain-Proline Interaction. J. Biol. Chem. 273: 21194-21202 [Abstract] [Full Text]  
• de Koning, J. P., Soede-Bobok, A. A., Schelen, A. M., Smith, L., van Leeuwen, D., Santini, V., Burgering, B. M.T., Bos, J. L., Lowenberg, B., Touw, I. P. (1998). Proliferation Signaling and Activation of Shc, p21Ras, and Myc Via Tyrosine 764 of Human Granulocyte Colony-Stimulating Factor Receptor. Blood 91: 1924-1933 [Abstract] [Full Text]  
• Tiganis, T., Bennett, A. M., Ravichandran, K. S., Tonks, N. K. (1998). Epidermal Growth Factor Receptor and the Adaptor Protein p52Shc Are Specific Substrates of T-Cell Protein Tyrosine Phosphatase. Mol. Cell. Biol. 18: 1622-1634 [Abstract] [Full Text]  
• Okada, S., Kao, A. W., Ceresa, B. P., Blaikie, P., Margolis, B., Pessin, J. E. (1997). The 66-kDa Shc Isoform Is a Negative Regulator of the Epidermal Growth Factor-stimulated Mitogen-activated Protein Kinase Pathway. J. Biol. Chem. 272: 28042-28049 [Abstract] [Full Text]  
• Hermanns, H. M., Radtke, S., Schaper, F., Heinrich, P. C., Behrmann, I. (2000). Non-redundant Signal Transduction of Interleukin-6-type Cytokines. THE ADAPTER PROTEIN Shc IS SPECIFICALLY RECRUITED TO THE ONCOSTATIN M RECEPTOR. J. Biol. Chem. 275: 40742-40748 [Abstract] [Full Text]  
• Iwashima, M., Takamatsu, M., Yamagishi, H., Hatanaka, Y., Huang, Y.-Y., McGinty, C., Yamasaki, S., Koike, T. (2002). Genetic evidence for Shc requirement in TCR-induced c-Rel nuclear translocation and IL-2 expression. Proc. Natl. Acad. Sci. USA 99: 4544-4549 [Abstract] [Full Text]